Adipotide / FTPP

Thermogenic / Adipolytic

Potential fat mass reduction through adipose tissue vascular apoptosis

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide
Primary mechanism: Adipose vasculature targeting
Primary market use: Obesity

Pharmacology

Molecular weight (Da): ~1990
Oral bioavailability: N/A
Half-life: 2 to 4 hours
Route tags: Route-dependent / verify
Evidence level: Animal
Clinical status: Experimental
Value-for-money score: 3 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Structural fat-cell compartment reduction candidate

Sources

https://pubmed.ncbi.nlm.nih.gov/